RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vanda Pharmaceuticals Stock

Vanda Pharmaceuticals Net Income 2024

Vanda Pharmaceuticals Net Income

-29.13 M USD

Ticker

VNDA

ISIN

US9216591084

WKN

A0JJT3

In 2024, Vanda Pharmaceuticals's profit amounted to -29.13 M USD, a -1,261.15% increase from the 2.51 M USD profit recorded in the previous year.

The Vanda Pharmaceuticals Net Income history

YEARNET INCOME (undefined USD)
2028e-
2027e-
2026e52.62
2025e15.76
2024e-29.13
20232.51
20226.3
202133.2
202023.3
2019115.6
201825.2
2017-15.6
2016-18
2015-39.9
201420.2
2013-21.1
2012-28.6
2011-9.8
20107.2
2009-35.9
2008-51.1
2007-74.1
2006-49.9
2005-50
2004-7.4

Vanda Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Vanda Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Vanda Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Vanda Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Vanda Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Vanda Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Vanda Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Vanda Pharmaceuticals’s growth potential.

Vanda Pharmaceuticals Revenue, EBIT and net profit per share

DateVanda Pharmaceuticals RevenueVanda Pharmaceuticals EBITVanda Pharmaceuticals Net Income
2028e245.82 M undefined0 undefined0 undefined
2027e295.8 M undefined20.4 M undefined0 undefined
2026e399.65 M undefined75.63 M undefined52.62 M undefined
2025e310.44 M undefined-1.46 M undefined15.76 M undefined
2024e205.55 M undefined-38.92 M undefined-29.13 M undefined
2023192.64 M undefined-13.95 M undefined2.51 M undefined
2022254.4 M undefined6.3 M undefined6.3 M undefined
2021268.7 M undefined62 M undefined33.2 M undefined
2020248.2 M undefined34.1 M undefined23.3 M undefined
2019227.2 M undefined22.8 M undefined115.6 M undefined
2018193.1 M undefined21.7 M undefined25.2 M undefined
2017165.1 M undefined-16.9 M undefined-15.6 M undefined
2016146 M undefined-18.6 M undefined-18 M undefined
2015109.9 M undefined-40.2 M undefined-39.9 M undefined
201450.2 M undefined-57.5 M undefined20.2 M undefined
201333.9 M undefined-21.2 M undefined-21.1 M undefined
201232.7 M undefined-29.2 M undefined-28.6 M undefined
201131.3 M undefined-10.7 M undefined-9.8 M undefined
201035.7 M undefined8.8 M undefined7.2 M undefined
20094.5 M undefined-35.9 M undefined-35.9 M undefined
20080 undefined-52.8 M undefined-51.1 M undefined
20070 undefined-80 M undefined-74.1 M undefined
20060 undefined-52.1 M undefined-49.9 M undefined
20050 undefined-16.9 M undefined-50 M undefined
20040 undefined-7.4 M undefined-7.4 M undefined

Vanda Pharmaceuticals stock margins

The Vanda Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vanda Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vanda Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Vanda Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Vanda Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Vanda Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Vanda Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Vanda Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Vanda Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Vanda Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Vanda Pharmaceuticals Margin History

Vanda Pharmaceuticals Gross marginVanda Pharmaceuticals Profit marginVanda Pharmaceuticals EBIT marginVanda Pharmaceuticals Profit margin
2028e92.32 %0 %0 %
2027e92.32 %6.9 %0 %
2026e92.32 %18.92 %13.17 %
2025e92.32 %-0.47 %5.08 %
2024e92.32 %-18.93 %-14.17 %
202392.32 %-7.24 %1.3 %
202290.45 %2.48 %2.48 %
202190.47 %23.07 %12.36 %
202090.57 %13.74 %9.39 %
201989.22 %10.04 %50.88 %
201889.38 %11.24 %13.05 %
201789.16 %-10.24 %-9.45 %
201683.08 %-12.74 %-12.33 %
201578.71 %-36.58 %-36.31 %
201496.81 %-114.54 %40.24 %
2013100 %-62.54 %-62.24 %
201299.69 %-89.3 %-87.46 %
2011100 %-34.19 %-31.31 %
201091.88 %24.65 %20.17 %
200957.78 %-797.78 %-797.78 %
200892.32 %0 %0 %
200792.32 %0 %0 %
200692.32 %0 %0 %
200592.32 %0 %0 %
200492.32 %0 %0 %

Vanda Pharmaceuticals Aktienanalyse

What does Vanda Pharmaceuticals do?

Vanda Pharmaceuticals Inc is a US biotechnology company specializing in the development and marketing of innovative therapies for neurological, psychiatric, and cardiovascular diseases. It was founded in 2002 by Mihael H. Polymeropoulos, who previously worked as a senior researcher at the genetic research company Novartis. Vanda Pharmaceuticals is based in Washington D.C. The company's business model focuses on developing and bringing to market medicines for rare diseases. It collaborates closely with clinics and research institutes to tailor innovative therapies and medications to the specific needs of patients. Vanda Pharmaceuticals operates in various areas, including neurology, psychiatry, and cardiology. In neurology, the company focuses on researching and developing therapies for rare diseases such as isolated sleeplessness syndrome and delayed sleep phase syndrome. In psychiatry, Vanda Pharmaceuticals has brought several medications to market for the treatment of schizophrenia, bipolar disorder, and depression. The medication Fanapt, in particular, has become a successful schizophrenia medication and has already been approved by the US FDA. In cardiology, Vanda Pharmaceuticals is working on the development of medications for the treatment of cardiovascular diseases such as heart failure and high blood pressure. One of Vanda Pharmaceuticals' most innovative therapy forms is chronotherapy, which involves timing the intake of certain medications to the body's natural circadian rhythm. The goal of chronotherapy is to maximize treatment effectiveness while minimizing side effects. An example of Vanda Pharmaceuticals' successes is the aforementioned medication Fanapt, which was approved by the FDA in 2009 and is distributed worldwide. Clinical studies have shown that Fanapt is safe and effective in the treatment of schizophrenia. The high expectations for the medication have led to Vanda Pharmaceuticals' listing on the NASDAQ and the company having a market value of several hundred million dollars. In conclusion, Vanda Pharmaceuticals is an innovative biotechnology company specializing in the research and development of therapies for rare diseases. With the successful introduction of medications like Fanapt, the company has established itself as an important player in the American and international markets. Vanda Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Vanda Pharmaceuticals's Profit Margins

The profit margins of Vanda Pharmaceuticals represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Vanda Pharmaceuticals's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Vanda Pharmaceuticals's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Vanda Pharmaceuticals's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Vanda Pharmaceuticals’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Vanda Pharmaceuticals stock

How much profit has Vanda Pharmaceuticals made this year?

Vanda Pharmaceuticals has made -29.13 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -1,261.15% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Vanda Pharmaceuticals publish its earnings?

Vanda Pharmaceuticals publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Vanda Pharmaceuticals?

The profits of Vanda Pharmaceuticals are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Vanda Pharmaceuticals?

You can learn more about the earnings of Vanda Pharmaceuticals by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Vanda Pharmaceuticals pay?

Over the past 12 months, Vanda Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vanda Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Vanda Pharmaceuticals?

The current dividend yield of Vanda Pharmaceuticals is .

When does Vanda Pharmaceuticals pay dividends?

Vanda Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vanda Pharmaceuticals?

Vanda Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Vanda Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vanda Pharmaceuticals located?

Vanda Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vanda Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vanda Pharmaceuticals from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Vanda Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Vanda Pharmaceuticals in the year 2023?

In the year 2023, Vanda Pharmaceuticals distributed 0 USD as dividends.

In which currency does Vanda Pharmaceuticals pay out the dividend?

The dividends of Vanda Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Vanda Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Vanda Pharmaceuticals

Our stock analysis for Vanda Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vanda Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.